First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs

Clinical Colorectal Cancer

Volumn 9, Issue 1, 2010, Pages 48-51

  Kawamura, Yutaka J ^a   Tokumitsu, Aika ^a   Mizokami, Ken ^a   Sasaki, Junichi ^a   Tsujinaka, Shingo ^a   Konishi, Fumio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Carbohydrate antigen; Carcinoembryonic antigen; Computed tomography; Tumor marker

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; SPLEEN; THORAX RADIOGRAPHY; TUMOR LOCALIZATION;

EID: 77149141792     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2010.n.006     Document Type: Article

References (24)

1. Kjeldsen BJ, Kronborg O, Fenger C, et al. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997; 84:666-669
2. Secco GB, Fardelli R, Gianquinto D, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 1997; 28:418-423
3. Rodríguez-Moranta F, Saló J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006; 24:386-393
4. Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003; 3:26.
5. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for nonmetastatic colorectal cancer. Cochrane Database Syst Rev 2002; CD002200.
6. Renehan AG, Egger M, Saunders MP, et al. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and metaanalysis of randomised trials. BMJ 2002; 324:813.
7. Desch CE, Benson AB III, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005; 23:8512-8519
8. Fucini C, Tommasi SM, Rosi S, et al. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. Dis Colon Rectum 1987; 30:273-277
9. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24:5313-5327
10. Katoh H, Yamashita K, Kokuba Y, et al. Surgical resection of stage IV colorectal cancer and prognosis. World J Surg 2008; 32:1130-1137
11. Liska V, Holubec L Jr, Treska V, et al. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases. Anticancer Res 2007; 27:2861-2864
12. Mineo TC, Ambrogi V, Tonini G, et al. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg 2003; 197:386-391
13. Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol 2003; 30:349-360
14. Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum 2007; 50:1783-1799
15. Nuzzo G, Giuliante F, Ardito F, et al. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 2008; 143:384-393
16. Alberts SR. Updated options for liver-limited metastatic colorectal cancer. Clin Colorectal Cancer 2008; 7(suppl 2):S58-62.
17. Shirouzu K, Isomoto H, Hayashi A, et al. Surgical treatment for patients with pulmonary metastases after resection of primary colorectal carcinoma. Cancer 1995; 76:393-398
18. Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 1996; 112:867-874
19. Zink S, Kayser G, Gabius HJ, et al. Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intrapulmonary metastases. Eur J Cardiothorac Surg 2001; 19:908-913
20. Vogelsang H, Haas S, Hierholzer C, et al. Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 2004; 91:1066-1071
21. Iizasa T, Suzuki M, Yoshida S, et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg 2006; 82:254-260
22. Paulet E, Aubé C, Pessaux P, et al. Factors limiting complete tumor ablation by radiofrequency ablation. Cardiovasc Intervent Radiol 2008; 31:107-115
23. Machi J, Oishi AJ, Sumida K, et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first-and second-line management. Cancer J 2006; 12:318-326
24. Yan TD, King J, Sjarif A, et al. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006; 13:1529-1537 (Pubitemid 44749666)